Brentuximab Vedotin in Advanced Hodgkin’s Lymphoma

Stephen M Ansell, John Radford, David J Straus

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1527-1528
Number of pages2
JournalThe New England Journal of Medicine
Issue number16
Publication statusPublished - 20 Oct 2022


  • Humans
  • Brentuximab Vedotin
  • Hodgkin Disease/drug therapy
  • Neoplasm Recurrence, Local/drug therapy
  • Immunoconjugates/adverse effects
  • Antineoplastic Combined Chemotherapy Protocols
  • Lymphoma

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Cite this